A personal health scare can reframe a career. For Ariel Ganz, a near-miss with breast cancer became the catalyst for a new investment thesis. She co-founded Arben Ventures, a fund dedicated to precision health and longevity, rather than pursuing a broader healthcare portfolio.
According to MedCity News, Arben has backed 83 early-stage startups in just three years. The fund's focus is narrow: technologies that target individual health profiles and extend healthy lifespan. Ganz's own experience appears to have sharpened that focus, making the fund's mission deeply personal.
The source does not provide details on specific portfolio companies or investment amounts, but it does highlight the speed and scale of Arben's early activity. The implication is that a founder's lived experience can directly shape an investment strategy, especially in a field as personal as medicine.